Patents by Inventor Camilla Gustafsen

Camilla Gustafsen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • INHIBITORS OF PCSK9 FOR TREATMENT OF LIPOPROTEIN METABOLISM DISORDERS
    Publication number: 20220072032
    Abstract: The present disclosure relates to inhibitors of proprotein convertase subtilisin-like/kexin type 9 (PCSK9) for the treatment of lipoprotein metabolism disorders.
    Type: Application
    Filed: November 22, 2021
    Publication date: March 10, 2022
    Inventors: Camilla Gustafsen, Peder Søndergaard Madsen, Simon Glerup Pedersen
  • COMPOUNDS FOR TREATMENT OF LIPOPROTEIN METABOLISM DISORDERS
    Publication number: 20220054530
    Abstract: The present disclosure relates to use of heparin analogues as inhibitors of proprotein convertase subtilisin-like/kexin type 9 (PCSK9) for the treatment of lipoprotein metabolism disorders.
    Type: Application
    Filed: August 16, 2021
    Publication date: February 24, 2022
    Inventors: Camilla Gustafsen, Peder Søndergaard Madsen, Simon Glerup Pedersen
  • Compounds for treatment of lipoprotein metabolism disorders
    Patent number: 11173177
    Abstract: The present disclosure relates to use of heparin analogues as inhibitors of proprotein convertase subtilisin-like/kexin type 9 (PCSK9) for the treatment of lipoprotein metabolism disorders.
    Type: Grant
    Filed: September 20, 2017
    Date of Patent: November 16, 2021
    Assignee: Aarhus Universitet
    Inventors: Camilla Gustafsen, Peder Sondergaard Madsen, Simon Glerup Pedersen
  • INHIBITORS OF PCSK9 FOR TREATMENT OF LIPOPROTEIN METABOLISM DISORDERS
    Publication number: 20200330504
    Abstract: The present disclosure relates to inhibitors of proprotein convertase subtilisin-like/kexin type 9 (PCSK9) for the treatment of lipoprotein metabolism disorders.
    Type: Application
    Filed: May 4, 2020
    Publication date: October 22, 2020
    Inventors: Camilla Gustafsen, Peder Sondergaard Madsen, Simon Glerup Pedersen
  • Inhibitors of PCSK9 for treatment of lipoprotein metabolism disorders
    Patent number: 10688119
    Abstract: The present disclosure relates to inhibitors of proprotein convertase subtilisin-like/kexin type 9 (PCSK9) for the treatment of lipoprotein metabolism disorders.
    Type: Grant
    Filed: March 18, 2016
    Date of Patent: June 23, 2020
    Assignee: Aarhus Universitet
    Inventors: Camilla Gustafsen, Peder Sondergaard Madsen, Simon Glerup Pedersen
  • COMPOUNDS FOR TREATMENT OF LIPOPROTEIN METABOLISM DISORDERS
    Publication number: 20190275074
    Abstract: The present disclosure relates to use of heparin analogues as inhibitors of proprotein convertase subtilisin-like/kexin type 9 (PCSK9) for the treatment of lipoprotein metabolism disorders.
    Type: Application
    Filed: September 20, 2017
    Publication date: September 12, 2019
    Inventors: Camilla Gustafsen, Peder Sondergaard Madsen, Simon Glerup Pedersen
  • INHIBITORS OF PCSK9 FOR TREATMENT OF LIPOPROTEIN METABOLISM DISORDERS
    Publication number: 20180193376
    Abstract: The present disclosure relates to inhibitors of proprotein convertase subtilisin-like/kexin type 9 (PCSK9) for the treatment of lipoprotein metabolism disorders.
    Type: Application
    Filed: March 18, 2016
    Publication date: July 12, 2018
    Inventors: Camilla Gustafsen, Peder Sondergaard Madsen, Simon Glerup Pedersen